Skip to content

No decline in AIDS Lymphomas

Once daily dual PIs on horizon

EuroSIDA Update: Tracking HIV in Europe

US treatment guidelines fall into line with UK

Salvage therapy drugs could reach Europe first

Tenofovir crisis appeal by European activists

STIs: more questions than answers

ddI capsules: why the new dosing advice?

Hep C limits immune recovery on HAART

How good are new CD4 cells on HAART?

Comprehensive Geneva conference summaries

Latest News from ICAAC

Resistance to ddI and d4T may be underestimated

Are you being treated well?

Most people with Hep C not developing liver toxicity on HAART

Delavirdine setback in Europe

Chicago: conference summaries

Europe rejects license for delavirdine, delays on amprenavir